The study examined how multiple longitudinal measures of sleep disturbances (sleep-initiation insomnia, sleep-maintenance insomnia, sleep-medication usage) are associated with dementia risk.
A recent study has established a connection between sleep-maintenance insomnia and a decrease in the likelihood of developing dementia while sleep-initiation insomnia and the use of sleep medication were associated with an increased risk of dementia.
A recent study has added to the growing evidence connecting sleep disturbances with cognitive impairment. The research found substantial correlations between three measures of sleep disturbance and the likelihood of developing dementia over the course of 10 years
According to a study published in the American Journal of Preventive Medicine by Elsevier, individuals who experience sleep-initiation insomnia (the inability to fall asleep within 30 minutes) and use sleep medication may be at a heightened risk for developing dementia. Conversely, the study found that those with sleep-maintenance insomnia (difficulty returning to sleep after waking) were less likely to develop dementia over the course of the investigation.
“We expected sleep-initiation insomnia and sleep medication usage to increase dementia risk, but we were surprised to find sleep-maintenance insomnia decreased dementia risk,” explained lead investigator Roger Wong, Ph.D., MPH, MSW, an Assistant Professor in the Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
“The motivation behind this research was prompted on a personal level. My father has been experiencing chronic sleep disturbances since the COVID-19 pandemic began, and I was concerned how this would affect his cognition in the future. After reading the existing literature, I was surprised to see mixed findings on the sleep-dementia relationship, so I decided to investigate this topic.”
This research is novel because it is the first to examine how long-term sleep disturbance measures are associated with dementia risk using a nationally representative US older adult sample. Previous research has associated REM sleep behavior, sleep deprivation (less than five hours of sleep), and the use of short-acting benzodiazepines with cognitive decline. Their results for sleep-maintenance insomnia support other recent studies using smaller, separate data samples.
This study used 10 annual waves (2011−2020) of prospective data from the National Health and Aging Trends Study (NHATS), a longitudinal panel study that surveys a nationally representative sample of Medicare beneficiaries aged 65 years and older within the USA. This study included only people who were dementia-free at baseline in 2011.
There is no cure for dementia and recent pharmaceutical approaches to treat dementia have had limited success, pointing to the importance of preventive approaches to dementia.
“By focusing on the variations in sleep disturbances, our findings can help to inform lifestyle changes that can reduce dementia risk,” explained co-investigator Margaret Anne Lovier, MPH, Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
While the mechanism for decreased dementia risk among those with sleep-maintenance insomnia is still unknown, the investigators theorize that greater engagement in activities that preserve or increase cognitive reserve may thereby decrease dementia risk.
Recent evidence indicates there is a higher prevalence of sleep disturbances among older adults than among other age groups. This could be attributed to a variety of factors including anxiety about the COVID-19 pandemic or warmer nights as a consequence of climate change.
“Older adults are losing sleep over a wide variety of concerns. More research is needed to better understand its causes and manifestations and limit the long-term consequences,” added Dr. Wong.
“Our findings highlight the importance of considering sleep disturbance history when assessing the dementia risk profile for older adults. Future research is needed to examine other sleep disturbance measures using a national longitudinal sample, whether these sleep-dementia findings hold true for specific dementia subtypes, and how certain sociodemographic characteristics may interact with sleep disturbances to influence dementia risk.”
Reference: “Sleep Disturbances and Dementia Risk in Older Adults: Findings From 10 Years of National U.S. Prospective Data” by Roger Wong and Margaret Anne Lovier, 26 January 2023, American Journal of Preventive Medicine.
DOI: 10.1016/j.amepre.2023.01.008
Here we go again, failing to factor-in long-term chronic nearly subclinical food (minimally) allergy reactions aggravated (or not) with FDA approved food poisoning (namely added MSG and soy) and/or related medical errors; blaming the dementia on the lack of sleep when given sufficient time the insomnia and the dementia have the same underlying cause. I’ve already emailed Dr. Wong about how postmenopausal women not on hormone therapy are more at risk, because estrogen is protective against serum uric acid, what appears to be the underlying mechanism that so-called “modern medicine” still fails to research.